World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: TCTR
Last refreshed on: 29 April 2024
Main ID:  TCTR20141128001
Date of registration: 28/11/2014
Prospective Registration: No
Primary sponsor: Faculty of Medicine Siriraj Hospital
Public title: Study the effects of Andrographis paniculata on platelet aggregation in Thai healthy volunteers: the pilot study
Scientific title: Study the effects of Andrographis paniculata on platelet aggregation in Thai healthy volunteers: the pilot study
Date of first enrolment: 25/04/2014
Target sample size:
Recruitment status: Completed
URL:  https://www.thaiclinicaltrials.org/show/TCTR20141128001
Study type:  Interventional
Study design:  Non-randomized  
Phase:  Phase 1
Countries of recruitment
Thailand
Contacts
Name: Assoc. Prof. Pravit    Akarasereenont
Address:  2 Wanglang Road Bangkoknoi 10700 Bangkok Thailand
Telephone: +662-419-5227
Email: pravit.auk@mahidol.ac.th
Affiliation:  Faculty of Medicine Siriraj Hospital
Name: Assoc. Prof. Pravit    Akarasereenont
Address:  2 Wanglang Road Bangkoknoi 10700 Bangkok Thailand
Telephone: +662-419-5227
Email: pravit.auk@mahidol.ac.th
Affiliation:  Faculty of Medicine Siriraj Hospital
Key inclusion & exclusion criteria
Inclusion criteria: 1. Male or female age between 25-60 years
2. Body mass index (BMI) between 18 to 24 kg/m^2
3. Who has been determined healthy physical examination, medical history, and vital signs
4. Female, non pregnant or use the contraceptive or not currently breast feeding and have negative pregnancy test
5. Who be willing to participate and signed the informed consent form

Exclusion criteria: 1. Who has history usage of other drugs, especially which can effect platelet aggregation
2. Who has history of allergic reactions or allergy to NSAIDs, Andrographis paniculata or its derivative compounds
3. Who is no smoke and alcohol
4. Who has donated blood within last 90 days before participate


Age minimum: 25 Years
Age maximum: 60 Years
Gender: Both
Health Condition(s) or Problem(s) studied
healthy human volunteers
Intervention(s)
All healthy volunteers was fasting for 12 hour before received 2 g of Andrographis paniculata capsules for 3 times in 4 hour intervals. Compared the effects of Andrographis paniculata before and after 2 and 24 hour administration.
Active Comparator Drug
Andrographis paniculata
Primary Outcome(s)
A. paniculata has the effect on platelet aggregation in human platelet 0, 2, and 24 hour after A. paniculata administration aggregation assay
Secondary Outcome(s)
A. paniculata has the effect on COX activity and P-selectin in human platelet aggregation 0, 2, and 24 hour after A. paniculata administration RT-PCR, Western blot and ELISA
Secondary ID(s)
Source(s) of Monetary Support
Faculty of Medicine Siriraj Hospital
Secondary Sponsor(s)
Faculty of Medicine Siriraj Hospital
Ethics review
Status: Submitted, approved
Approval date:
Contact:
Siriraj Institutional Review Board
Results
Results available:
Date Posted:
Date Completed: 28/05/2014
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history